Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1952 1
1956 2
1998 1
2016 1
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Hemolytic anemias recent advances in diagnosis and treatment.
EVANS RS, DUANE R. EVANS RS, et al. Calif Med. 1949 Apr;70(4):244-51. Calif Med. 1949. PMID: 18116227 Free PMC article.
Splenectomy is the only effective treatment in congenital hemolytic jaundice and in acquired hemolytic anemia; the operation should be carried out promptly in most cases. Transfusion may be used in all varieties of hemolytic disease and is the o …
Splenectomy is the only effective treatment in congenital hemolytic jaundice and in acquired hemolytic anemia; t …
Extravascular hemolysis and complement consumption in Paroxysmal Nocturnal Hemoglobinuria patients undergoing eculizumab treatment.
Subías Hidalgo M, Martin Merinero H, López A, Anter J, García SP, Ataúlfo Gonzalez-Fernández F, Forés R, Lopez-Trascasa M, Villegas A, Ojeda E, Rodríguez de Córdoba S. Subías Hidalgo M, et al. Immunobiology. 2017 Feb;222(2):363-371. doi: 10.1016/j.imbio.2016.09.002. Epub 2016 Sep 13. Immunobiology. 2017. PMID: 27644115 Free article.
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hemolytic anemia characterized by complement-mediated intravascular hemolysis that is effectively treated with eculizumab. ...
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hemolytic anemia characterized by complement-mediated intravas …
Diagnosis and treatment of acquired hemolytic anemia.
SACKS MS, JAHN EF, WORKMAN JB. SACKS MS, et al. J Am Med Assoc. 1952 Dec 20;150(16):1556-9. doi: 10.1001/jama.1952.03680160006002. J Am Med Assoc. 1952. PMID: 12990469 No abstract available.
Circulating primitive stem cells in paroxysmal nocturnal hemoglobinuria (PNH) are predominantly normal in phenotype but granulocyte colony-stimulating factor treatment mobilizes mainly PNH stem cells.
Johnson RJ, Rawstron AC, Richards S, Morgan GJ, Norfolk DR, Hillmen SO. Johnson RJ, et al. Blood. 1998 Jun 15;91(12):4504-8. Blood. 1998. PMID: 9616145 Free article.
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hemolytic anemia resulting from a somatic mutation in a hemopoietic stem cell. In most cases of hemolytic PNH, the majority of the marrow cells are derived from the PNH clone. ...
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hemolytic anemia resulting from a somatic mutation in a hemopo …